Quick Answer
CAPRICOR THERAPEUTICS, INC. reported Total Revenue of $0.00 for fiscal year 2025.
CAPRICOR THERAPEUTICS, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $0.00 | -100.0% |
| 2024 | $22.27M | -11.5% |
| 2023 | $25.18M | +886.8% |
| 2022 | $2.55M | +941.8% |
| 2021 | $244.9K | -21.1% |
| 2020 | $310.2K | -69.1% |
| 2019 | $1.01M | -39.9% |
| 2018 | $1.67M | -37.3% |
| 2017 | $2.67M | -33.3% |
| 2016 | $4.00M | -27.5% |
| 2015 | $5.52M | +15.3% |
| 2014 | $4.79M | +851.2% |
| 2013 | $503.2K | +157.4% |
| 2012 | $195.5K | -85.6% |
| 2011 | $1.35M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $2.26M | -63.4% | -43.1% |
| June 30, 2024 | $3.97M | +1.4% | -19.1% |
| March 31, 2024 | $4.91M | +64.3% | -20.7% |
| September 30, 2023 | $6.19M | +288.7% | +57.9% |
| June 30, 2023 | $3.92M | — | +31.2% |
| March 31, 2023 | $2.99M | — | +87.7% |
| September 30, 2022 | $1.59M | — | +679.9% |
| June 30, 2021 | $204.1K | +309.3% | +400.0% |
- CAPRICOR THERAPEUTICS, INC. showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- Over the 2011–2025 period, CAPRICOR THERAPEUTICS, INC.’s total revenue has declined by 100.0% (from $1.35 million to $0.00).
- The most recent figure is from CAPRICOR THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: